234.00
price up icon0.93%   2.1207
 
loading
전일 마감가:
$231.88
열려 있는:
$233.93
하루 거래량:
52,134
Relative Volume:
0.10
시가총액:
$9.06B
수익:
$1.24B
순이익/손실:
$42.23M
주가수익비율:
220.76
EPS:
1.06
순현금흐름:
$150.33M
1주 성능:
-0.16%
1개월 성능:
-8.03%
6개월 성능:
-14.52%
1년 성능:
+24.28%
1일 변동 폭
Value
$231.55
$234.89
1주일 범위
Value
$226.66
$234.89
52주 변동 폭
Value
$148.00
$310.00

Penumbra Inc Stock (PEN) Company Profile

Name
명칭
Penumbra Inc
Name
전화
(510) 995-2486
Name
주소
ONE PENUMBRA PLACE, ALAMEDA, CA
Name
직원
4,500
Name
트위터
@penumbrainc
Name
다음 수익 날짜
2025-02-18
Name
최신 SEC 제출 서류
Name
PEN's Discussions on Twitter

PEN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
PEN
Penumbra Inc
234.01 9.16B 1.24B 42.23M 150.33M 1.06
Medical Devices icon
ABT
Abbott Laboratories
125.06 228.77B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
107.39 153.09B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
400.42 149.27B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
91.75 114.31B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
76.79 45.06B 5.54B 4.18B 623.10M 7.00

Penumbra Inc Stock (PEN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-14 개시 BofA Securities Buy
2025-01-21 개시 UBS Buy
2024-12-17 개시 Oppenheimer Outperform
2024-12-11 업그레이드 Wells Fargo Equal Weight → Overweight
2024-09-18 개시 Stifel Buy
2024-09-03 개시 Leerink Partners Outperform
2024-07-31 다운그레이드 Citigroup Buy → Neutral
2024-07-31 다운그레이드 Wells Fargo Overweight → Equal Weight
2024-02-23 다운그레이드 JP Morgan Overweight → Neutral
2023-09-06 개시 Morgan Stanley Equal-Weight
2023-07-19 개시 Robert W. Baird Outperform
2023-03-29 다운그레이드 Needham Buy → Hold
2023-01-30 개시 Piper Sandler Overweight
2022-11-04 업그레이드 Citigroup Neutral → Buy
2022-10-12 개시 Jefferies Buy
2022-10-05 다운그레이드 Citigroup Buy → Neutral
2022-09-09 업그레이드 Needham Hold → Buy
2022-07-18 개시 RBC Capital Mkts Outperform
2022-04-19 개시 Deutsche Bank Buy
2022-03-08 개시 Needham Hold
2021-09-16 개시 Truist Buy
2021-06-04 업그레이드 BTIG Research Neutral → Buy
2020-12-16 다운그레이드 BTIG Research Buy → Neutral
2020-10-07 재개 Canaccord Genuity Buy
2020-09-29 개시 BTIG Research Buy
2020-09-08 다운그레이드 BofA Securities Buy → Neutral
2020-03-05 개시 Citigroup Buy
2019-06-13 재확인 BofA/Merrill Buy
2019-05-30 업그레이드 JP Morgan Neutral → Overweight
2019-05-21 개시 William Blair Outperform
2018-10-29 재개 BofA/Merrill Buy
2018-10-08 개시 RBC Capital Mkts Outperform
2018-02-21 개시 William Blair Outperform
2018-01-02 다운그레이드 JP Morgan Overweight → Neutral
2015-11-30 재확인 Canaccord Genuity Buy
2015-10-13 개시 Wells Fargo Outperform
모두보기

Penumbra Inc 주식(PEN)의 최신 뉴스

pulisher
Jul 22, 2025

Is Penumbra Inc. a good long term investmentFree Stock Chart Pattern Guide - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Penumbra Inc. Stock Analysis and ForecastPhenomenal returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Penumbra Inc. stockExplosive capital gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Penumbra (PEN) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance

Jul 22, 2025
pulisher
Jul 22, 2025

Penumbra, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025 - Eastern Progress

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Penumbra Inc. stock priceBreakthrough profits - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

Penumbra, Inc.'s (NYSE:PEN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - simplywall.st

Jul 20, 2025
pulisher
Jul 19, 2025

Penumbra's Strategic Growth Potential Bolstered by Upcoming Thunderbolt System Launch and Aspiration Technology Innovation - AInvest

Jul 19, 2025
pulisher
Jul 14, 2025

Penumbra CEO's Stock Sale: A Routine Maneuver or Cause for Concern? - AInvest

Jul 14, 2025
pulisher
Jul 14, 2025

Penumbra Insider Sold Shares Worth $3,896,344, According to a Recent SEC Filing - MarketScreener

Jul 14, 2025
pulisher
Jul 11, 2025

Penumbra CEO Elsesser sells $3.89m in shares By Investing.com - Investing.com Nigeria

Jul 11, 2025
pulisher
Jul 11, 2025

Penumbra CEO Elsesser sells $3.89m in shares - Investing.com Australia

Jul 11, 2025
pulisher
Jul 11, 2025

NeoGenomics, RadNet, Pediatrix Medical Group, Penumbra, and Neogen Shares Plummet, What You Need To Know - Yahoo Finance

Jul 11, 2025
pulisher
Jul 10, 2025

Penumbra (PEN) Announces Completion of Enrollment in STORM-PE Clinical Trial - Insider Monkey

Jul 10, 2025
pulisher
Jul 09, 2025

Penumbra (PEN) Sees Price Target Reduction by Citi Ahead of Earnings | PEN Stock News - GuruFocus

Jul 09, 2025
pulisher
Jul 06, 2025

Penumbra, Inc.'s (NYSE:PEN) P/S Still Appears To Be Reasonable - 富途牛牛

Jul 06, 2025
pulisher
Jul 03, 2025

Insider Sell: Johanna Roberts Sells 600 Shares of Penumbra Inc (PEN) - GuruFocus

Jul 03, 2025
pulisher
Jul 03, 2025

Penumbra EVP Roberts sells $151k in company stock By Investing.com - Investing.com Canada

Jul 03, 2025
pulisher
Jul 03, 2025

Penumbra EVP Roberts sells $151k in company stock - Investing.com

Jul 03, 2025
pulisher
Jul 01, 2025

Penumbra Inc EVP Sells 571 Shares for $144,143.47 on July 1, 2025. - AInvest

Jul 01, 2025
pulisher
Jun 28, 2025

Penumbra CEO Adam Elsesser sells $4m in stock on June 25 - Investing.com Nigeria

Jun 28, 2025
pulisher
Jun 26, 2025

Penumbra: AI Meets AspirationWhy The Stock Is A Structural Winner - Seeking Alpha

Jun 26, 2025
pulisher
Jun 23, 2025

Thrombectomy Devices Market | Advancing Stroke Treatment & Clot - openPR.com

Jun 23, 2025
pulisher
Jun 20, 2025

The Top 5 Analyst Questions From Penumbra’s Q1 Earnings Call - Yahoo Finance

Jun 20, 2025
pulisher
Jun 19, 2025

Insider Selling: Bridget O'Rourke Sells Shares of Penumbra Inc (PEN) - GuruFocus

Jun 19, 2025
pulisher
Jun 18, 2025

Penumbra director O’Rourke sells $12988 in stock - Investing.com

Jun 18, 2025
pulisher
Jun 17, 2025

Inquis, Penumbra advance thrombectomy treatments - BioWorld MedTech

Jun 17, 2025
pulisher
Jun 17, 2025

Transcript : Penumbra, Inc. Presents at 2025 Truist Securities MedTech Conference, Jun-17-2025 10 - MarketScreener

Jun 17, 2025
pulisher
Jun 16, 2025

Penumbra, Inc. Announces Completion of Enrollment for Landmark S - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Penumbra Completes Enrollment for STORM-PE Randomized Controlled Trial - Diagnostic and Interventional Cardiology

Jun 16, 2025
pulisher
Jun 16, 2025

Penumbra completes enrollment in pulmonary embolism trial - MassDevice

Jun 16, 2025
pulisher
Jun 16, 2025

Penumbra's Revolutionary PE Treatment Trial Hits 100-Patient Mark, Results Could Transform Blood Clot Care - Stock Titan

Jun 16, 2025
pulisher
Jun 13, 2025

Clot Management Devices Market Set to Witness Significant - openPR.com

Jun 13, 2025
pulisher
Jun 10, 2025

PEN Stock Rises Following the Launch of Ruby XL System - MSN

Jun 10, 2025
pulisher
Jun 10, 2025

RSI Alert: Penumbra (PEN) Now Oversold - Nasdaq

Jun 10, 2025
pulisher
Jun 09, 2025

Zacks Industry Outlook Penumbra, Integer and AngioDynamics - Yahoo Finance

Jun 09, 2025
pulisher
Jun 09, 2025

Penumbra Introduces the Ruby XL System – the Longest, Largest, and Softest Coil on the Market for Vascular Embolization - HMP Global Learning Network

Jun 09, 2025

Penumbra Inc (PEN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Penumbra Inc 주식 (PEN) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Elsesser Adam
CEO and President
Jul 09 '25
Sale
243.75
15,985
3,896,344
134,432
$285.50
price down icon 0.00%
medical_devices STE
$224.72
price up icon 0.46%
medical_devices PHG
$25.69
price up icon 2.82%
$86.05
price up icon 1.00%
$77.22
price up icon 0.94%
medical_devices EW
$76.74
price up icon 0.60%
자본화:     |  볼륨(24시간):